THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT

Go back to THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
(NASDAQ: TBPH) Delayed: 16.86 +0.05 (0.30%)
Previous Close $16.81    52 Week High $38.92 
Open $16.85    52 Week Low $12.87 
Day High $16.88    P/E N/A 
Day Low $16.83    EPS $0.00 
Volume 269,633